(E)-2-cyano-2-((Z)-3-ethyl-4-oxo-5-(((3-(2-(pyrrolidin-1-yl)ethyl)phenyl)amino)methylene)thiazolidin-2-ylidene)-N-(trifluoromethyl)acetamide

ID: ALA5281562

Max Phase: Preclinical

Molecular Formula: C22H24F3N5O2S

Molecular Weight: 479.53

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCn1c(=O)/c(=C/Nc2cccc(CCN3CCCC3)c2)s/c1=C(\C#N)C(=O)NC(F)(F)F

Standard InChI:  InChI=1S/C22H24F3N5O2S/c1-2-30-20(32)18(33-21(30)17(13-26)19(31)28-22(23,24)25)14-27-16-7-5-6-15(12-16)8-11-29-9-3-4-10-29/h5-7,12,14,27H,2-4,8-11H2,1H3,(H,28,31)/b18-14-,21-17+

Standard InChI Key:  JINUYEMGHKIEKW-ADDAYVOGSA-N

Molfile:  

 
     RDKit          2D

 33 35  0  0  0  0  0  0  0  0999 V2000
    4.4252    1.1247    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.8398    0.4115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2501    1.1272    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.7030    0.0442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3404   -0.4732    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.0307   -0.0285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8189    0.7673    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9998    0.8084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5533    1.4973    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0903   -0.1661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3049   -0.9586    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0985   -1.1690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6763   -0.5855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4691   -0.7954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6844   -1.5885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1004   -2.1717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3098   -1.9588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0479   -0.2130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8416   -0.4231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4203    0.1592    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2938    0.9671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0241    1.3422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6064    0.7634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2359    0.0308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3355    1.4054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0410    2.1717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7963   -0.3248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9226   -1.1359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4357    0.1900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2015   -0.1061    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3095    1.0013    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0485   -1.9443    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6064    0.1124    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  4  1  0
  8  9  2  0
  4 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 14 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 20  1  0
  7 25  1  0
 25 26  1  0
  6 27  2  0
 27 28  1  0
 27 29  1  0
 29 30  1  0
 30  2  1  0
 29 31  2  0
 28 32  3  0
  2 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5281562

    ---

Associated Targets(Human)

PLK1 Tchem Serine/threonine-protein kinase PLK1 (28605 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa S3 (477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Caco-2 (12174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16-F10 (4610 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 479.53Molecular Weight (Monoisotopic): 479.1603AlogP: 1.73#Rotatable Bonds: 7
Polar Surface Area: 90.16Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.40CX Basic pKa: 9.62CX LogP: 2.33CX LogD: 1.38
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.59Np Likeness Score: -1.57

References

1. Kaminskyy D, Kryshchyshyn A, Lesyk R..  (2017)  5-Ene-4-thiazolidinones - An efficient tool in medicinal chemistry.,  140  [PMID:28987611] [10.1016/j.ejmech.2017.09.031]

Source